133 related articles for article (PubMed ID: 31066494)
1. Peptide Amphiphile Supramolecular Nanostructures as a Targeted Therapy for Atherosclerosis.
Mansukhani NA; Peters EB; So MM; Albaghdadi MS; Wang Z; Karver MR; Clemons TD; Laux JP; Tsihlis ND; Stupp SI; Kibbe MR
Macromol Biosci; 2019 Jun; 19(6):e1900066. PubMed ID: 31066494
[TBL] [Abstract][Full Text] [Related]
2. Self-Assembled Peptide Amphiphile Nanofibers for Controlled Therapeutic Delivery to the Atherosclerotic Niche.
Peters EB; Karver MR; Sun K; Gillis DC; Biswas S; Clemons TD; He W; Tsihlis ND; Stupp SI; Kibbe MR
Adv Ther (Weinh); 2021 Sep; 4(9):. PubMed ID: 34926792
[TBL] [Abstract][Full Text] [Related]
3. Targeted Nanotherapeutics Encapsulating Liver X Receptor Agonist GW3965 Enhance Antiatherogenic Effects without Adverse Effects on Hepatic Lipid Metabolism in Ldlr
Yu M; Amengual J; Menon A; Kamaly N; Zhou F; Xu X; Saw PE; Lee SJ; Si K; Ortega CA; Choi WI; Lee IH; Bdour Y; Shi J; Mahmoudi M; Jon S; Fisher EA; Farokhzad OC
Adv Healthc Mater; 2017 Oct; 6(20):. PubMed ID: 28730752
[TBL] [Abstract][Full Text] [Related]
4. Atheroma Niche-Responsive Nanocarriers for Immunotherapeutic Delivery.
Peters EB; Tsihlis ND; Karver MR; Chin SM; Musetti B; Ledford BT; Bahnson EM; Stupp SI; Kibbe MR
Adv Healthc Mater; 2019 Feb; 8(3):e1801545. PubMed ID: 30620448
[TBL] [Abstract][Full Text] [Related]
5. Peptide Amphiphile Nanostructures for Targeting of Atherosclerotic Plaque and Drug Delivery.
So MM; Mansukhani NA; Peters EB; Albaghdadi MS; Wang Z; Pérez CMR; Kibbe MR; Stupp SI
Adv Biosyst; 2018 Mar; 2(3):. PubMed ID: 30666317
[TBL] [Abstract][Full Text] [Related]
6. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
[TBL] [Abstract][Full Text] [Related]
7. Complement Receptor Targeted Liposomes Encapsulating the Liver X Receptor Agonist GW3965 Accumulate in and Stabilize Atherosclerotic Plaques.
Benne N; Martins Cardoso R; Boyle AL; Kros A; Jiskoot W; Kuiper J; Bouwstra J; Van Eck M; Slütter B
Adv Healthc Mater; 2020 May; 9(10):e2000043. PubMed ID: 32329226
[TBL] [Abstract][Full Text] [Related]
8. The secretome of liver X receptor agonist-treated early outgrowth cells decreases atherosclerosis in Ldlr-/- mice.
Rasheed A; Shawky SA; Tsai R; Jung RG; Simard T; Saikali MF; Hibbert B; Rayner KJ; Cummins CL
Stem Cells Transl Med; 2021 Mar; 10(3):479-491. PubMed ID: 33231376
[TBL] [Abstract][Full Text] [Related]
9. [Advances in the study of anti-atherosclerosis drugs].
Guo CB; Li S
Yao Xue Xue Bao; 2007 Mar; 42(3):231-5. PubMed ID: 17520819
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
[TBL] [Abstract][Full Text] [Related]
11. Immune cell screening of a nanoparticle library improves atherosclerosis therapy.
Tang J; Baxter S; Menon A; Alaarg A; Sanchez-Gaytan BL; Fay F; Zhao Y; Ouimet M; Braza MS; Longo VA; Abdel-Atti D; Duivenvoorden R; Calcagno C; Storm G; Tsimikas S; Moore KJ; Swirski FK; Nahrendorf M; Fisher EA; Pérez-Medina C; Fayad ZA; Reiner T; Mulder WJ
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6731-E6740. PubMed ID: 27791119
[TBL] [Abstract][Full Text] [Related]
12. Supramolecular Assembly of Peptide Amphiphiles.
Hendricks MP; Sato K; Palmer LC; Stupp SI
Acc Chem Res; 2017 Oct; 50(10):2440-2448. PubMed ID: 28876055
[TBL] [Abstract][Full Text] [Related]
13. A tenascin-C mimetic peptide amphiphile nanofiber gel promotes neurite outgrowth and cell migration of neurosphere-derived cells.
Berns EJ; Álvarez Z; Goldberger JE; Boekhoven J; Kessler JA; Kuhn HG; Stupp SI
Acta Biomater; 2016 Jun; 37():50-8. PubMed ID: 27063496
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Redox-Responsive LXR-Activating Nanoparticle Formulations in Primary Mouse Macrophages.
Smith TKT; Kahiel Z; LeBlond ND; Ghorbani P; Farah E; Al-Awosi R; Cote M; Gadde S; Fullerton MD
Molecules; 2019 Oct; 24(20):. PubMed ID: 31635211
[TBL] [Abstract][Full Text] [Related]
15. T-shaped Peptide Amphiphiles Self Assemble into Nanofiber Networks.
Fisusi FA; Notman R; Granger LA; Malkinson JP; Schatzlein AG; Uchegbu IF
Pharm Nanotechnol; 2017; 5(3):215-219. PubMed ID: 28847269
[TBL] [Abstract][Full Text] [Related]
16. Nanomaterials to Resolve Atherosclerosis.
Peters EB; Kibbe MR
ACS Biomater Sci Eng; 2020 Jul; 6(7):3693-3712. PubMed ID: 33463318
[TBL] [Abstract][Full Text] [Related]
17. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice.
Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2009-15. PubMed ID: 18787185
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis.
Giannarelli C; Cimmino G; Connolly TM; Ibanez B; Ruiz JM; Alique M; Zafar MU; Fuster V; Feuerstein G; Badimon JJ
Eur Heart J; 2012 Jan; 33(2):264-73. PubMed ID: 21606082
[TBL] [Abstract][Full Text] [Related]
19. Dip-pen patterning and surface assembly of peptide amphiphiles.
Jiang H; Stupp SI
Langmuir; 2005 Jun; 21(12):5242-6. PubMed ID: 15924443
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
Padovani AM; Molina MF; Mann KK
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
